Atherosclerosis and Lipoproteins |
From the Division of Gasteroenterology and Nutrition (G.L.W., E.T.A., M.R.J., S.L-K., M.C.P., G.H.R.), The Childrens Hospital of Philadelphia, and the Department of Medicine (D.J.R.), University of Pennsylvania School of Medicine, Philadelphia, Pa.
Correspondence to Ginny L. Weibel, Division of Gasteroenterology and Nutrition, The Childrens Hospital of Philadelphia, Philadelphia, PA 19104-4399. E-mail weibel{at}email.chop.edu
Objective— The present study is a comparative investigation of cellular lipid mobilization and efflux to lipid-free human apoA-I and apoA-IMilano, reconstituted high-density lipoprotein (rHDL) particles containing these proteins and serum isolated from mice expressing human apoA-I or apoA-IMilano.
Methods and Results— Cholesterol and phospholipid efflux to these acceptors was measured in cell systems designed to assess the contributions of ATP-binding cassette A1 (ABCA1), scavenger receptor type BI (SRBI), and cellular lipid content to cholesterol and phospholipid efflux. Acceptors containing the Milano variant of apoA-I showed no functional increase in lipid efflux in all assays when compared with wild-type apoA-I. In fact, in some systems, acceptors containing the Milano variant of apoA-I promoted significantly less efflux than the acceptors containing wild-type apoA-I (apoA-Iwt). Additionally, intracellular cholesteryl ester hydrolysis in macrophage foam cells was not different in the presence of either apoA-IMilano or apoA-Iwt.
Conclusion— Collectively these studies suggest that if the Milano variant of apoA-I offers greater atheroprotection than wild-type apoA-I, it is not attributable to greater cellular lipid mobilization.
The present study is a comparative investigation of cellular lipid mobilization to human apoA-I and apoA-IMilano. Efflux was measured in cell systems designed to assess the contributions ABCA1 and SR-BI. Acceptors containing the Milano variant of apoA-I showed no functional increase in lipid efflux when compared with wild-type apoA-I.
Key Words: apolipoprotein A-I HDL cholesterol efflux apoA-IMilano
This article has been cited by other articles:
![]() |
E. T. Alexander, G. L. Weibel, M. R. Joshi, C. Vedhachalam, M. de la Llera-Moya, G. H. Rothblat, M. C. Phillips, and D. J. Rader Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1496 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Alexander, M. Tanaka, M. Kono, H. Saito, D. J. Rader, and M. C. Phillips Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I J. Lipid Res., July 1, 2009; 50(7): 1409 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Duong, G. L. Weibel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Characterization and properties of pre{beta}-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I J. Lipid Res., May 1, 2008; 49(5): 1006 - 1014. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |